UnknownNot Applicable

10-week Leucine Supplementation in Cerebral Palsy

United Kingdom25 participantsStarted 2018-08-20

Plain-language summary

The purpose of this study is to assess the effects of 10-weeks leucine supplementation on muscle growth, metabolism, body composition, inflammation and wellbeing in adolescents and young adults with CP.

Who can participate

Age range12 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * A diagnosis of spastic cerebral palsy * Aged 12-22 years Exclusion Criteria: * Orthopaedic surgery of the upper-limbs in the past 12 months * Botulinum toxin type A injections in the past 6 months * Serial casting in the past 6 months * Insufficient cognitive understanding to comply with the assessment procedures and intervention * Liver and/or kidney dysfunction

What they're measuring

Skeletal muscle volume

Timeframe: 10 weeks

Trial details

NCT IDNCT03668548

SponsorSt Mary's University College

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-10-22

View on ClinicalTrials.gov More Cerebral Palsy trials